Back to search

University of Thessaly (UTH)

Η συγκριτική επίδραση της βραχυχρόνιας χορήγησης της ροφεκοξίμπης, της μελοξικάμης, της ινδομεθακίνης και της πρεδνιζολόνης στην πώρωση των καταγμάτων: πειραματική μελέτη σε λευκούς κόνικλους New Zealand

Abstract

dc:description

Background: The use of nonsteroidal anti-inflammatory drugs in the management of pain due to a fracture is common clinical practice. There is clear evidence in the literature that classic nonsteroidal anti-inflammatory drugs delay fracture healing. The goal of our study is to determine the effect of short-term administration of specific COX-2 inhibitors in fracture healing. Methods: A nondisplaced osteotomy of the mid-diaphysis of the right ulna was performed in 40 adult male New Zealand rabbits. Rabbits were divided in five groups: control, prednisolone (2.5 mg/Kg/day im), indomethacin (2 mg/Kg/day per os), meloxicam (0.3 mg/Kg/day im) and rofecoxib (0.5 mg/Kg/day per os). Drugs were administered for five days only, starting on the day of surgery. Fracturehealing was assessed radiographically in a weekly basis. Rabbits were killed six weeks postoperatively, both ulnae were obtained and were subjected to biomechanical tests (three point bending) and histomorphometric measurements. Results: At six weeks there was clear delay in healing in the groups of prednisolone and indomethacin, radiographically, biomechanically andhistologically. The biomechanical parameters were 36-51% lower in the prednisolone group and 29-37% lower in the indomethacin group, compared to the control (p<0.05). In the meloxicam group a delay in healing was also observed and the biomechanical parameters were reduced at a level of 16-21% (p<0.05) when compared to those of the control. However, in six out of the thirteenhistomorphometric parameters measured there were no statistically significant differences (p>0.05). The mildest delay in fracture healing was observed in the rofecoxib group, in which the values of stiffness (3% lower) and toughness (22% higher) and the values of six out of thirteen histomorphometric parameters had no statistically significant differences (p>0.05) compared to the control. Conclusions: Our study shows that short-term administration of selective COX-2 inhibitors did not affect the state stages of secondary non-osteonal bone healing and that the mild delay observed in the early stages of healing is both dosedepended and reversible. The more selective the anti-COX-2 is, the less negative effect on bone healing is observed. Clinical Relevance: Our data suggest that ifthere is a need for anti-inflammatory drugs administration in fracture, selective COX-2 inhibitors should be preferred and administration should be as short-term as possible.

Degree

thesis:*
Grantor dc:publisher
University of Thessaly (UTH)
Year dc:date
2007

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Boursinos, Loukas
  • Μπουρσινός, Λουκάς

Subjects

dc:subject × 10

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/34130

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Boursinos, Loukas; Μπουρσινός, Λουκάς. Η συγκριτική επίδραση της βραχυχρόνιας χορήγησης της ροφεκοξίμπης, της μελοξικάμης, της ινδομεθακίνης και της πρεδνιζολόνης στην πώρωση των καταγμάτων: πειραματική μελέτη σε λευκούς κόνικλους New Zealand. University of Thessaly (UTH), 2007. http://hdl.handle.net/10442/hedi/34130